These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35126385)

  • 1. Editorial: Immune Cell Lineage Reprogramming in Cancer.
    Leavenworth JW; Shi LZ; Wang X; Wei H
    Front Immunol; 2021; 12():838464. PubMed ID: 35126385
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
    Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
    Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance.
    Traba J; Sack MN; Waldmann TA; Anton OM
    Front Immunol; 2021; 12():657293. PubMed ID: 34079545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Fate Reprogramming in the Era of Cancer Immunotherapy.
    Zimmermannova O; Caiado I; Ferreira AG; Pereira CF
    Front Immunol; 2021; 12():714822. PubMed ID: 34367185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate lymphoid cells and cancer at border surfaces with the environment.
    Mattiola I; Diefenbach A
    Semin Immunol; 2019 Feb; 41():101278. PubMed ID: 31473072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cancer metabolic reprogramming and immune response.
    Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
    Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages: from mechanisms to therapy.
    Noy R; Pollard JW
    Immunity; 2014 Jul; 41(1):49-61. PubMed ID: 25035953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
    Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
    Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Yin and Yang of Innate Lymphoid Cells in Cancer.
    Carrega P; Campana S; Bonaccorsi I; Ferlazzo G
    Immunol Lett; 2016 Nov; 179():29-35. PubMed ID: 27296768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies.
    Dong Y; Wan Z; Gao X; Yang G; Liu L
    Front Immunol; 2021; 12():609762. PubMed ID: 33968014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.
    Wellenstein MD; de Visser KE
    Immunity; 2018 Mar; 48(3):399-416. PubMed ID: 29562192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
    Wu D
    Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
    Yan L; Tan Y; Chen G; Fan J; Zhang J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Inflammatory Treg reprogramming in the tumor immune microenvironment.
    Deng X; Su Y; Fu H; Gao Y; Liu P
    Front Immunol; 2024; 15():1411923. PubMed ID: 38715611
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Iron Metabolism at the Crossroad of Innate Immune Response and Cancer Progression.
    Zacchi P; Recalcati S
    Front Immunol; 2021; 12():832886. PubMed ID: 35069607
    [No Abstract]   [Full Text] [Related]  

  • 16. Parallels between artificial reprogramming and the biogenesis of cancer stem cells: Involvement of lncRNAs.
    Rasmussen TP
    Semin Cancer Biol; 2019 Aug; 57():36-44. PubMed ID: 30273656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer: pathological nuclear reprogramming?
    Goding CR; Pei D; Lu X
    Nat Rev Cancer; 2014 Aug; 14(8):568-73. PubMed ID: 25030952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy.
    Wennerberg E; Lundqvist A; Mao Y; Mougiakakos D
    Front Immunol; 2021; 12():718844. PubMed ID: 34276709
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.
    Lu B; Yang M; Wang Q
    J Mol Med (Berl); 2016 May; 94(5):535-43. PubMed ID: 26922618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.